181 related articles for article (PubMed ID: 16631133)
1. Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models.
Chen J; Lipska BK; Weinberger DR
Biol Psychiatry; 2006 Jun; 59(12):1180-8. PubMed ID: 16631133
[TBL] [Abstract][Full Text] [Related]
2. Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment.
Lu L; Mamiya T; Koseki T; Mouri A; Nabeshima T
Biol Pharm Bull; 2011; 34(9):1358-63. PubMed ID: 21881217
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.
O'Tuathaigh CM; Babovic D; O'Meara G; Clifford JJ; Croke DT; Waddington JL
Neurosci Biobehav Rev; 2007; 31(1):60-78. PubMed ID: 16782199
[TBL] [Abstract][Full Text] [Related]
4. The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates.
Dawe GS; Ratty AK
Biotechnol J; 2007 Nov; 2(11):1344-52. PubMed ID: 17886239
[TBL] [Abstract][Full Text] [Related]
5. Inducible and conditional transgenic mouse models of schizophrenia.
Pletnikov MV
Prog Brain Res; 2009; 179():35-47. PubMed ID: 20302816
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.
Gogos JA
Int Rev Neurobiol; 2007; 78():397-422. PubMed ID: 17349868
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic function in relation to genes associated with risk for schizophrenia: translational mutant mouse models.
Moran PM; O'Tuathaigh CM; Papaleo F; Waddington JL
Prog Brain Res; 2014; 211():79-112. PubMed ID: 24968777
[TBL] [Abstract][Full Text] [Related]
8. Mutant models for genes associated with schizophrenia.
Desbonnet L; Waddington JL; O'Tuathaigh CM
Biochem Soc Trans; 2009 Feb; 37(Pt 1):308-12. PubMed ID: 19143653
[TBL] [Abstract][Full Text] [Related]
9. [Risk genes for schizophrenia and neuronal plasticity: molecular target for antipsychotic discovery].
Hashimoto R; Yasuda Y; Ohi K; Fukumoto M; Yamamori H; Takeda M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):103-7. PubMed ID: 20666140
[TBL] [Abstract][Full Text] [Related]
10. Gene models of schizophrenia: DISC1 mouse models.
Jaaro-Peled H
Prog Brain Res; 2009; 179():75-86. PubMed ID: 20302820
[TBL] [Abstract][Full Text] [Related]
11. Genetic animal models for schizophrenia: advantages and limitations of genetic manipulation in drosophila, zebrafish, rodents, and primates.
Sawa A
Prog Brain Res; 2009; 179():3-6. PubMed ID: 20302812
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.
Srivastava V; Deshpande SN; Thelma BK
Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of genetic effects on cognition: relevance to schizophrenia.
Papaleo F; Lipska BK; Weinberger DR
Neuropharmacology; 2012 Mar; 62(3):1204-20. PubMed ID: 21557953
[TBL] [Abstract][Full Text] [Related]
14. Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development.
Kamiya A
Prog Brain Res; 2009; 179():9-15. PubMed ID: 20302813
[TBL] [Abstract][Full Text] [Related]
15. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.
Williams M
Curr Opin Investig Drugs; 2003 Jan; 4(1):31-6. PubMed ID: 12625025
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility genes for schizophrenia].
Itokawa M; Yoshikawa T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():437-40. PubMed ID: 16416830
[No Abstract] [Full Text] [Related]
17. The changing roles and targets for animal models of schizophrenia.
Kilts CD
Biol Psychiatry; 2001 Dec; 50(11):845-55. PubMed ID: 11743940
[TBL] [Abstract][Full Text] [Related]
18. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.
Perlman WR; Weickert CS; Akil M; Kleinman JE
J Psychiatry Neurosci; 2004 Jul; 29(4):287-93. PubMed ID: 15309045
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
[TBL] [Abstract][Full Text] [Related]
20. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules.
Mouri A; Nagai T; Ibi D; Yamada K
Neurobiol Dis; 2013 May; 53():61-74. PubMed ID: 23142533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
